Phosphofructokinase type 1 kinetics, isoform expression, and gene polymorphisms in cancer cells

Journal of Cellular Biochemistry

Volumn 113, Issue 5, 2012, Pages 1692-1703

  Moreno Sánchez, Rafael ^a   Marín Hernández, Alvaro ^a   Gallardo Pérez, Juan Carlos ^a   Quezada, Héctor ^a   Encalada, Rusely ^a   Rodríguez Enríquez, Sara ^a   Saavedra, Emma ^a  

^a INSTITUTO NACIONAL DE CARDIOLOGÍA IGNACIO CHÁVEZ   (Mexico)

Author keywords

COOPERATIVE CONCERTED TRANSITION KINETIC MODEL; NON ESSENTIAL HYPERBOLIC ACTIVATION; PASTEUR EFFECT; TUMOR GLYCOLYSIS

Indexed keywords

6 PHOSPHOFRUCTOKINASE; ADENOSINE TRIPHOSPHATE; CITRIC ACID; FRUCTOSE 2,6 BISPHOSPHATE; FRUCTOSE 6 PHOSPHATE; MESSENGER RNA; POTASSIUM ION;

ARTICLE; CANCER CELL; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ANALYSIS; ENZYME KINETICS; ENZYME LOCALIZATION; ENZYME SUBSTRATE; GENETIC POLYMORPHISM; HEART; HUMAN; HUMAN CELL; LIVER; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEOMICS; TISSUE DISTRIBUTION;

ANIMALS; BASE SEQUENCE; BREAST NEOPLASMS; CELL LINE, TUMOR; DNA, COMPLEMENTARY; ENZYME ACTIVATION; FEMALE; HELA CELLS; HUMANS; KINETICS; LIVER; LIVER NEOPLASMS, EXPERIMENTAL; MYOCARDIUM; NEOPLASMS; PHOSPHOFRUCTOKINASE-1; PHOSPHOFRUCTOKINASE-1, LIVER TYPE; PHOSPHOFRUCTOKINASE-1, MUSCLE TYPE; PHOSPHOFRUCTOKINASE-1, TYPE C; POLYMORPHISM, GENETIC; RATS; RATS, WISTAR; SUBSTRATE SPECIFICITY; UTERINE CERVICAL NEOPLASMS;

RATTUS; RODENTIA;

EID: 84859048398     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.24039     Document Type: Article

References (49)

1. Banaszak K, Mechin I, Obmolova G, Oldham M, Chang SH, Ruiz T, Radermacher M, Kopperschlager G, Rypniewski W,. 2011. The crystal structures of eukaryotic phosphofructokinases from baker's yeast and rabbit skeletal muscle. J Mol Biol 407: 284-297.
2. Barker J, Khan MA, Solomos T,. 1966. Mechanism of the Pasteur effect. Nature 211: 547-548.
3. Bergmeyer HU,. 1974. Methods of enzymatic analysis, 1st edition. Weinheim: Verlag Chemie.
4. Clem B, Telang S, Clem A, Yalcin A, Meier J, Simmons A, Rasku MA, Arumugam S, Dean WL, Eaton J, Lane A, Trent JO, Chesney J,. 2008. Small-molecule inhibition of 6-phosphofructo-2-kinase activity suppresses glycolytic flux and tumor growth. Mol Cancer Ther 7: 110-120.
5. Colomer D, Vives-Corrons JL, Pujades A, Bartrons R,. 1987. Control of phosphofructokinase by fructose 2,6-bisphosphate in B-lymphocytes and B-chronic lymphocytic leukemia cells. Cancer Res 47: 1859-1862. (Pubitemid 17056690)
6. Denis C, Paris H, Murat JC,. 1986. Hormonal control of fructose 2,6-bisphosphate concentration in the HT29 human colon adenocarcinoma cell line. Alpha 2-adrenergic agonists counteract effect of vasoactive intestinal peptide. Biochem J 239: 531-536. (Pubitemid 17219385)
7. dos Santos MA, Borges JB, de Almeida DC, Curi R,. 2004. Metabolism of the microregions of human breast cancer. Cancer Lett 216: 243-248. (Pubitemid 39463328)
8. Dunaway GA, Kasten TP, Sebo T, Trapp R,. 1988. Analysis of the phosphofructokinase subunits and isoenzymes in human tissues. Biochem J 251: 677-683.
9. Eigenbrodt E, Glossmann H,. 1980. Glycolysis: one of the keys to cancer? Trends Pharmacol Sci 1: 240-245.
10. El-Bacha T, de Freitas MS, Sola-Penna M,. 2003. Cellular distribution of phosphofructokinase activity and implications to metabolic regulation in human breast cancer. Mol Genet Metab 79: 294-299. (Pubitemid 37013538)
11. Gerweck LE, Vijayappa S, Kozin S,. 2006. Tumor pH controls the in vivo efficacy of weak acid and base chemotherapeutics. Mol Cancer Ther 5: 1275-1279. (Pubitemid 43881320)
12. Jannaschk D, Burgos M, Centerlles JJ, Ovadi J, Cascante M,. 1999. Application of metabolic control analysis to the study of toxic effects of copper in muscle glycolysis. FEBS Lett 445: 144-148. (Pubitemid 29101550)
13. Kashiwaya Y, Sato K, Tsuchiya N, Thomas S, Fell DA, Veech RL, Passonneau JV,. 1994. Control of glucose utilization in working perfused rat heart. J Biol Chem 269: 25502-25514. (Pubitemid 24336239)
14. Koster JF, Slee RG, Van Berkel TJ,. 1980. Isoenzymes of human phosphofructokinase. Clin Chim Acta 103: 169-173. (Pubitemid 10138826)
15. Lehotzky A, Telegdi M, Liliom K, Ovadi J,. 1993. Interaction of phosphofructokinase with tubulin and microtubules. Quantitative evaluation of the mutual effects. J Biol Chem 268: 10888-10894. (Pubitemid 23162269)
16. Loiseau AM, Rousseau GG, Hue L,. 1985. Fructose 2,6-bisphosphate and the control of glycolysis by glucocorticoids and by other agents in rat hepatoma cells. Cancer Res 45: 4263-4269. (Pubitemid 16224884)
17. López-Gómez FJ, Torres-Márquez ME, Moreno-Sánchez R,. 1993. Control of oxidative phosphorylation in AS-30D hepatoma mitochondria. Int J Biochem 25: 373-377. (Pubitemid 23071815)
18. Maharaj B, Pillay S,. 1991. " Tru-Cut" needle biopsy of the liver: importance of the correct technique. Postgrad Med J 67: 170-173.
19. Marín-Hernández A, Rodríguez-Enríquez S, Vital-González PA, Flores-Rodríguez FL, Macias-Silva M, Sosa-Garrocho M, Moreno-Sánchez R,. 2006. Determining and understanding the control of glycolysis in fast-growth tumor cells. Flux control by an over-expressed but strongly product-inhibited hexokinase. FEBS J 273: 1975-1988.
20. Marín-Hernández A, Gallardo-Perez JC, Ralph SJ, Rodríguez-Enríquez S, Moreno-Sánchez R,. 2009. HIF-1alpha modulates energy metabolism in cancer cells by inducing over-expression of specific glycolytic isoforms. Mini Rev Med Chem 9: 1084-1101.
21. Marín-Hernández A, Gallardo-Perez JC, Rodríguez- Enríquez S, Encalada R, Moreno-Sánchez R, Saavedra E,. 2011. Modeling cancer glycolysis. Biochim Biophys Acta 1807: 755-767.
22. Meldolesi MF, Macchia V, Laccetti P,. 1976. Differences in phosphofructokinase regulation in normal and tumor rat thyroid cells. J Biol Chem 251: 6244-6251.
23. Moeller LC, Dumitrescu AM, Refetoff S,. 2005. Cytosolic action of thyroid hormone leads to induction of hypoxia-inducible factor-1alpha and gycolytic genes. Mol Endocrinol 19: 2955-2963. (Pubitemid 41697714)
24. Mojena M, Bosca L, Hue L,. 1985. Effect of glutamine on fructose 2,6-bisphosphate and on glucose metabolism in HeLa cells and in chick-embryo fibroblasts. Biochem J 232: 521-527. (Pubitemid 16210787)
25. Moreno-Sánchez R, Rodríguez-Enríquez S, Marín-Hernández A, Saavedra E,. 2007. Energy metabolism in tumor cells. FEBS J 274: 1393-1418. (Pubitemid 46333738)
26. Moreno-Sánchez R, Rodríguez-Enríquez S, Saavedra E, Marín-Hernández A, Gallardo-Pérez JC,. 2009. 2009The bioenergetics of cancer: is glycolysis the main ATP supplier in all tumor cells? Biofactors 35: 209-225.
27. Nakashima RA, Paggi MG, Scott LJ, Pedersen PL,. 1988. Purification and characterization of a bindable form of mitochondrial bound hexokinase from the highly glycolytic AS-30D rat hepatoma cell line. Cancer Res 48: 913-919. (Pubitemid 18061886)
28. Nascimben L, Ingwall JS, Lorell BH, Pinz I, Schultz V, Tornheim K, Tian R,. 2004. Mechanisms for increased glycolysis in the hypertrophied rat heart. Hypertension 44: 662-667. (Pubitemid 39435236)
29. Nissler K, Petermann H, Wenz I, Brox D,. 1995. Fructose 2,6-bisphosphate metabolism in Ehrlich ascites tumour cells. J Cancer Res Clin Oncol 121: 739-745.
30. Oskam R, Rijksen G, Staal GE, Vora S,. 1985. Isozymic composition and regulatory properties of phosphofructokinase from well-differentiated and anaplastic medullary thyroid carcinomas of the rat. Cancer Res 45: 135-142. (Pubitemid 15196945)
31. Rankin EB, Giaccia AJ,. 2008. The role of hypoxia-inducible factors in tumorigenesis. Cell Death Differ 15: 678-685. (Pubitemid 351405072)
32. Rapoport TA, Heinrich R, Jacobasch G, Rapoport S,. 1974. A linear steady-state treatment of enzymatic chains. A mathematical model of glycolysis of human erythrocytes. Eur J Biochem 42: 107-120.
33. Rodríguez-Enríquez S, Juarez O, Rodríguez-Zavala JS, Moreno-Sánchez R,. 2001. Multisite control of the Crabtree effect in ascites hepatoma cells. Eur J Biochem 268: 2512-2519. (Pubitemid 32417780)
34. Saavedra E, Encalada R, Pineda E, Jasso-Chávez R, Moreno-Sánchez R,. 2005. Glycolysis in Entamoeba histolytica. Biochemical characterization of recombinant glycolytic enzymes and flux control analysis. FEBS J 272: 1767-1783. (Pubitemid 40516226)
35. Sánchez-Martínez C, Aragón JJ,. 1997. Analysis of phosphofructokinase subunits and isozymes in ascites tumor cells and its original tissue, murine mammary gland. FEBS Lett 409: 86-90.
36. Sánchez-Martínez C, Estevez AM, Aragón JJ,. 2000. Phosphofructokinase C isozyme from ascites tumor cells: cloning, expression, and properties. Biochem Biophys Res Commun 271: 635-640. (Pubitemid 30444680)
37. Segel IH,. 1975. Enzyme kinetics, 1st edition. New York: Wiley.
38. Semenza GL, Roth PH, Fang HM, Wang GL,. 1994. Transcriptional regulation of genes encoding glycolytic enzymes by hypoxia-inducible factor 1. J Biol Chem 269: 23757-23763. (Pubitemid 24293585)
39. Shonk CE, Arison RN, Koven BJ, Majima H, Boxer GE,. 1965. Enzyme patterns in human tissues. 3. Glycolytic enzymes in normal and malignant tissues of the colon and rectum. Cancer Res 25: 206-213.
40. Staal GE, Kalff A, Heesbeen EC, van Veelen CW, Rijksen G,. 1987. Subunit composition, regulatory properties, and phosphorylation of phosphofructokinase from human gliomas. Cancer Res 47: 5047-5051. (Pubitemid 17146470)
41. Stubbs M, Bashford CL, Griffiths JR,. 2003. Understanding the tumor metabolic phenotype in the genomic era. Curr Mol Med 3: 49-59. (Pubitemid 36131677)
42. Torres NV, Mateo F, Melendez-Hevia E, Kacser H,. 1986. Kinetics of metabolic pathways. A system in vitro to study the control of flux. Biochem J 234: 169-174. (Pubitemid 16053672)
43. Traut TW,. 1994. Physiological concentrations of purines and pyrimidines. Mol Cell Biochem 140: 1-22. (Pubitemid 24379884)
44. Van Schaftingen E, Jett MF, Hue L, Hers HG,. 1981. Control of liver 6-phosphofructokinase by fructose 2,6-bisphosphate and other effectors. Proc Natl Acad Sci USA 78: 3483-3486. (Pubitemid 11059314)
45. Vertessy BG, Kovacs J, Ovadi J,. 1996. Specific characteristics of phosphofructokinase-microtubule interaction. FEBS Lett 379: 191-195. (Pubitemid 26037852)
46. Vogt M, Puntschart A, Geiser J, Zuleger C, Billeter R, Hoppeler H,. 2001. Molecular adaptations in human skeletal muscle to endurance training under stimulated hypoxic conditions. J Appl Physiol 91: 173-182. (Pubitemid 32574722)
47. Vora S, Halper JP, Knowles DM,. 1985a. Alterations in the activity and isozymic profile of human phosphofructokinase during malignant transformation in vivo and in vitro: transformation- and progression-linked discriminants of malignancy. Cancer Res 45: 2993-3001. (Pubitemid 15007163)
48. Vora S, Oskam R, Staal GE,. 1985b. Isoenzymes of phosphofructokinase in the rat. Demonstration of the three non-identical subunits by biochemical, immunochemical and kinetic studies. Biochem J 229: 333-341. (Pubitemid 15232041)
49. Zorzano A, Balon TW, Brady LJ, Rivera P, Garetto LP, Young JC, Goodman MN, Ruderman NB,. 1985. Effects of starvation and exercise on concentrations of citrate, hexose phosphates and glycogen in skeletal muscle and heart. Evidence for selective operation of the glucose-fatty acid cycle. Biochem J 232: 585-591. (Pubitemid 16210795)